CVKD - Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. (CVKD)

NCM · Common · CUSIP 127636108

Last Price•••.••

Current Yield•.••%

Yield to Call•.••%

Yield to Worst•.••%

Free registration unlocks the quote, yield calculations, price chart and full fundamentals for CVKD and every other security on QuantumOnline.

Overview Financials 🔒 Earnings 🔒 Dividends 🔒 Analysts 🔒 Ownership 🔒 ESG 🔒 Technicals 🔒

🔒

Price chart and 15 days of daily prices

Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type: Common Stock
CUSIP: 127636108
Market Cap: Micro Cap
IPO: 1/20/2023 · $5.00/share

Links: Home Page Investor Relations News

Business: Cadrenal Therapeutics, Inc. is focused on developing tecarfarin, a novel cardiorenal therapy with orphan drug designation for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease,

Company Contact

CEO: Quang Pham
CFO: Matthew Szot
Headquarters: 822 A1A North, Suite 320, Ponte Vedra, FL 32082
Phone: 904-300-0701
Investor Relations: Matthew Szot · 858-337-0766
SEC EDGAR Filings: View filings »